Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 results assess the efficacy and safety of FIRTECH in adults with mild to moderate acute low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FIRTECH

Snippet

Sponsor: Sanofi | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19